Pleiotropic effects of Bcl-2 on transcription factors in T cells: Potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2

V. N. Ivanov, G. Deng, E. R. Podack, Thomas Malek

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Bcl-2 functions to repress apoptosis by regulation of genes which encode proteins required for programmed cell death and by interference with peroxidative damage. We investigated the interrelationship between expression of bcl-2 and regulation of transcription factor DNA binding activities in the 2B4 T cell hybridoma and IL-2-dependent CTLL T cell line. Over-expression of bcl-2 in 2B4 resulted in enhanced basal levels of activator protein (AP)-1, octamer binding factor (Oct)-1, lymphoid enhancer binding factor (LEF)-1, RelA-p50 and NF-κB p50-p50 DNA binding activities. After apoptotic signaling, down-regulation of AP-1, NF-AT and Oct-1 binding activities was observed in control 2B4 and CTLL, whereas suboptimal, but higher, levels of these transcription factors were found in bcl-2-transfected cells, potentially promoting cell survival. Furthermore, after apoptotic signaling, expression of bcl-2 led to differential changes of NF-κB levels, resulting in a decrease in RelA-p50 and an increase in NF-κB p50-p50, altering the ratio of these DNA binding activities such that now p50-p50 markedly predominated in both 2B4-Bcl-2 and CTLL-Bcl-2. Apoptotic signaling in the presence or absence of Bcl-2 resulted in induction of the RelB-p50 heterodimer in 2B4. The changes in NF-κB/Rel levels raise the possibility that this family of transcription factors may play an important role in the regulation of apoptosis.

Original languageEnglish
Pages (from-to)1709-1720
Number of pages12
JournalInternational Immunology
Volume7
Issue number11
StatePublished - Jan 1 1995

Fingerprint

Bcl-2
Transcription factors
T-cells
Cell death
Transcription Factor
DNA
Transcription Factors
Transcription Factor AP-1
Proteins
T-Lymphocytes
Lymphoid Enhancer-Binding Factor 1
Apoptosis
Apoptosis Regulatory Proteins
Hybridomas
Interleukin-2
Cell Survival
Down-Regulation
Genes
Protein
Cells

Keywords

  • AP-1
  • Apoptosis
  • Dexamethasone
  • IL-2
  • NF-κB/Rel
  • NF-AT

ASJC Scopus subject areas

  • Immunology
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Neuropsychology and Physiological Psychology
  • Transplantation

Cite this

Pleiotropic effects of Bcl-2 on transcription factors in T cells : Potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2. / Ivanov, V. N.; Deng, G.; Podack, E. R.; Malek, Thomas.

In: International Immunology, Vol. 7, No. 11, 01.01.1995, p. 1709-1720.

Research output: Contribution to journalArticle

@article{a5958cc6ee754def9d1a406d449f85ef,
title = "Pleiotropic effects of Bcl-2 on transcription factors in T cells: Potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2",
abstract = "Bcl-2 functions to repress apoptosis by regulation of genes which encode proteins required for programmed cell death and by interference with peroxidative damage. We investigated the interrelationship between expression of bcl-2 and regulation of transcription factor DNA binding activities in the 2B4 T cell hybridoma and IL-2-dependent CTLL T cell line. Over-expression of bcl-2 in 2B4 resulted in enhanced basal levels of activator protein (AP)-1, octamer binding factor (Oct)-1, lymphoid enhancer binding factor (LEF)-1, RelA-p50 and NF-κB p50-p50 DNA binding activities. After apoptotic signaling, down-regulation of AP-1, NF-AT and Oct-1 binding activities was observed in control 2B4 and CTLL, whereas suboptimal, but higher, levels of these transcription factors were found in bcl-2-transfected cells, potentially promoting cell survival. Furthermore, after apoptotic signaling, expression of bcl-2 led to differential changes of NF-κB levels, resulting in a decrease in RelA-p50 and an increase in NF-κB p50-p50, altering the ratio of these DNA binding activities such that now p50-p50 markedly predominated in both 2B4-Bcl-2 and CTLL-Bcl-2. Apoptotic signaling in the presence or absence of Bcl-2 resulted in induction of the RelB-p50 heterodimer in 2B4. The changes in NF-κB/Rel levels raise the possibility that this family of transcription factors may play an important role in the regulation of apoptosis.",
keywords = "AP-1, Apoptosis, Dexamethasone, IL-2, NF-κB/Rel, NF-AT",
author = "Ivanov, {V. N.} and G. Deng and Podack, {E. R.} and Thomas Malek",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "7",
pages = "1709--1720",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Pleiotropic effects of Bcl-2 on transcription factors in T cells

T2 - Potential role of NF-κB p50-p50 for the anti-apoptotic function of Bcl-2

AU - Ivanov, V. N.

AU - Deng, G.

AU - Podack, E. R.

AU - Malek, Thomas

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Bcl-2 functions to repress apoptosis by regulation of genes which encode proteins required for programmed cell death and by interference with peroxidative damage. We investigated the interrelationship between expression of bcl-2 and regulation of transcription factor DNA binding activities in the 2B4 T cell hybridoma and IL-2-dependent CTLL T cell line. Over-expression of bcl-2 in 2B4 resulted in enhanced basal levels of activator protein (AP)-1, octamer binding factor (Oct)-1, lymphoid enhancer binding factor (LEF)-1, RelA-p50 and NF-κB p50-p50 DNA binding activities. After apoptotic signaling, down-regulation of AP-1, NF-AT and Oct-1 binding activities was observed in control 2B4 and CTLL, whereas suboptimal, but higher, levels of these transcription factors were found in bcl-2-transfected cells, potentially promoting cell survival. Furthermore, after apoptotic signaling, expression of bcl-2 led to differential changes of NF-κB levels, resulting in a decrease in RelA-p50 and an increase in NF-κB p50-p50, altering the ratio of these DNA binding activities such that now p50-p50 markedly predominated in both 2B4-Bcl-2 and CTLL-Bcl-2. Apoptotic signaling in the presence or absence of Bcl-2 resulted in induction of the RelB-p50 heterodimer in 2B4. The changes in NF-κB/Rel levels raise the possibility that this family of transcription factors may play an important role in the regulation of apoptosis.

AB - Bcl-2 functions to repress apoptosis by regulation of genes which encode proteins required for programmed cell death and by interference with peroxidative damage. We investigated the interrelationship between expression of bcl-2 and regulation of transcription factor DNA binding activities in the 2B4 T cell hybridoma and IL-2-dependent CTLL T cell line. Over-expression of bcl-2 in 2B4 resulted in enhanced basal levels of activator protein (AP)-1, octamer binding factor (Oct)-1, lymphoid enhancer binding factor (LEF)-1, RelA-p50 and NF-κB p50-p50 DNA binding activities. After apoptotic signaling, down-regulation of AP-1, NF-AT and Oct-1 binding activities was observed in control 2B4 and CTLL, whereas suboptimal, but higher, levels of these transcription factors were found in bcl-2-transfected cells, potentially promoting cell survival. Furthermore, after apoptotic signaling, expression of bcl-2 led to differential changes of NF-κB levels, resulting in a decrease in RelA-p50 and an increase in NF-κB p50-p50, altering the ratio of these DNA binding activities such that now p50-p50 markedly predominated in both 2B4-Bcl-2 and CTLL-Bcl-2. Apoptotic signaling in the presence or absence of Bcl-2 resulted in induction of the RelB-p50 heterodimer in 2B4. The changes in NF-κB/Rel levels raise the possibility that this family of transcription factors may play an important role in the regulation of apoptosis.

KW - AP-1

KW - Apoptosis

KW - Dexamethasone

KW - IL-2

KW - NF-κB/Rel

KW - NF-AT

UR - http://www.scopus.com/inward/record.url?scp=0028827284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028827284&partnerID=8YFLogxK

M3 - Article

C2 - 8580069

AN - SCOPUS:0028827284

VL - 7

SP - 1709

EP - 1720

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 11

ER -